Michael Gelband’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,187
Closed -$235K 2220
2022
Q4
$235K Sell
9,187
-8,140
-47% -$187K ﹤0.01% 1419
2022
Q3
$335K Buy
+17,327
New +$349K ﹤0.01% 1494
2021
Q3
Sell
-95,301
Closed -$1.65M 2806
2021
Q2
$1.65M Buy
+95,301
New +$1.57M 0.02% 768
2020
Q4
Sell
-36,578
Closed -$345K 2491
2020
Q3
$345K Sell
36,578
-86,069
-70% -$952K 0.01% 1212
2020
Q2
$1.4M Buy
+122,647
New +$1.54M 0.04% 578
2019
Q4
Sell
-9,598
Closed -$208K 1984
2019
Q3
$208K Sell
9,598
-2,370
-20% -$59.8K 0.01% 1111
2019
Q2
$363K Buy
+11,968
New +$394K 0.01% 601

Other funds holding AVTA

Michael Gelband's AVTA Position: Q1 2023 in Review

Michael Gelband sold out of Avantax, Inc. Common Stock (AVTA) in Q1 2023, closing a stake of 9,187 shares — an estimated $235K sold.

Michael Gelband first reported a position in AVTA in Q2 2019 and held it in 7 quarters. The position peaked at $1.65M in Q2 2021. 154 funds tracked by Wall St. Rank hold AVTA as of Q1 2023.

  • Michael Gelband reported no remaining Avantax, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Michael Gelband sold 9,187 Avantax, Inc. Common Stock shares in Q1 2023, an estimated $235K.
  • Michael Gelband first reported a position in Avantax, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Michael Gelband's Avantax, Inc. Common Stock position peaked at $1.65M in Q2 2021.
  • 154 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q1 2023.

Based on ExodusPoint Capital Management's 13F filing for Q1 2023, filed 11 May 2023.